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Abstract
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Human CAG repeat diseases manifest themselves through the common pathology of
neurodeneration. This pathological link is attributed to the property shared by all nine of
these diseases: an expanded polyglutamine (polyQ) tract. The most evident result of
polyQ expansion is protein aggregation, and it is believed that this phenomenon is partly
responsible for conferring cytotoxic properties on the mutated protein. Apart from
sequestering the mutated protein, cellular aggregates are able to incorporate native
proteins via polyQ-mediated aggregation, thus disrupting important cellular pathways.
Using Drosophila melanogaster as a disease model, researchers have been able to
compile collections of these so-called disease modifiers for most of the CAG repeat
diseases. Moreover, a recently characterized Drosophila gene, Dikar, appears to
synergistically react with polyQ-expanded proteins in an especially strong fashion,
causing a synthetic lethal phenotype. One potential mechanism by which Dikar causes
synthetic lethality involves the genetic construct used to achieve ectopic gene expression:
the Gal4-UAS system in conjunction with the Drosophila eye-specific transcription
factor Glass and its enhancer sequence GMR. A suspected chromatin remodelling
complex, Dikar may create a feedback loop involving GMR that would result in
increased polyQ expression and thus cell death. To test whether this phenomenon was
responsible for synthetic lethality, a (GFP) reporter gene assay was carried out using two
versions of GMR: longGMR and shortGMR. The findings of this study demonstrated that
Dikar did not affect GMR-driven expression levels of the GFP reporter. Therefore, it was
concluded that synthetic lethality is not the result of a self-perpetuating circuit but rather
involves either direct or indirect interactions between Dikar and the polyQ protein.
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CAG repeat expansion mutations are a type of genetic aberration responsible for nine
human neurodegenerative diseases, including X-linked spinobulbar muscular atrophy, a
series of cerebellar atrophies, and Huntington’s disease.1 In these diseases, native regions
of CAG repeats become expanded within the protein-coding regions of affected genes; as
a result, the mutation is manifested in the protein products as an expanded stretch of
glutamine residues.2 The mechanism(s) by which native polyglutamine (polyQ)
sequences become expanded remain unclear. One hypothesis postulates that during the
processes of DNA replication and/or DNA repair, a phenomenon termed strand slippage
occurs in the relatively unstable polyQ region of the gene, with the result of increasing
the number of CAG trinucleotide units.3 While numerous genes possess native polyQ
sequences, the length of these structures remains stable at ∼30Q; an increase to 35Q will
become a risk factors for disease while expansions beyond 40Q will almost certainly lead
to a disease phenotype.4 Moreover, the number of CAG copies is correlated both with the
severity of the disease as well as the age of onset, with longer polyQ stretches being more
detrimental.2,4 In terms of inheritance, CAG repeat diseases are autosomal dominant;
physiologically, the expanded polyglutamine stretch leads to a dual loss-of-function and
gain-of-function mutation of affected genes.5
Despite their occurrence among different genes located throughout distinct areas
of the genome, CAG repeat mutations result in common pathological manifestations.
Mainly, all polyQ expansion-induced diseases are characterized by a senescence of the
central nervous system and its associated structures.6 In Huntington’s disease, the
affected gene is responsible for the production of the huntingtin protein.7 Normal
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huntingtin is expressed ubiquitously in humans and is present at higher levels in the

neurons of the CNS, especially in the brain striatum.5 Crucially, neuronal cells exhibit
increased sensitivity to the polyQ-mutated form of huntingtin (mHtt), with research
demonstrating that neurons die from cytoplasmic mHtt concentrations that do not
significantly disrupt the functions of other cell types.8 This phenomenon has also been
observed in other CAG repeat diseases; consequently, the disease phenotypes are the
direct result of gradual brain atrophy. The symptoms of CAG repeat-induced
neurodegeneration, while varied across the individual diseases, include motor function
impairment, psychological alterations, and cognitive decline, with all nine diseases
resulting in either symptoms development or even death at approximately the fifth decade
of life.9
Due to the phenotypic similarities of CAG repeat diseases, it is clear that the
expanded polyQ region plays a crucial role in initiating pathological processes. Indeed,
this novel structure significantly alters the physiological properties of the affected
protein. Most importantly, the expanded polyQ stretch confers aggregating capabilities on
the mutated protein, leading to the gain-of-function aspect of the mutation. Depending on
the size of the expanded polyQ stretch, mutants will exhibit significant β-structure and/or
protofibril characteristics.10 These structural changes are responsible for aberrant protein
folding that leads to protein aggregation at the molecular level as well as inclusion, or
aggresome, formation at the microscopic level. Interestingly, polyQ-mutated proteins do
not appear to be capable of inducing conformational changes that lead to aggregation of
wild-type protein.11 Thus, the presence of an expanded polyQ region is necessary for this
phenomenon to take place.
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The role of aggregation in disease development is currently a point of debate. Due
to the phenotypic similarities of CAG repeat diseases to other neurodegenerative diseases
that exhibit amyloid-like protein inclusions, it has been proposed that the molecular event
of aggregation is a critical milestone that leads to the development of polyQ-mutated
protein cytotoxicity.12 Moreover, the fact that the length of the mutated polyQ region is
related both to enhanced aggregation capabilities as well as the severity of pathology
suggests that aggregation contributes significantly to disease development. Not only do
aggregates sequester the mutated protein, leading to the loss-of-function aspect of the
mutation, but they also are able to recruit other native proteins that contain wild-type
polyQ stretches.13,14 Thus, aggregation has the potential to disrupt vital cellular pathways.
Nevertheless, the role of inclusions, or aggresomes, in the disease process has
been suggested to be beneficial. On the one hand, aggresomes seem to be a final result of
the molecular phenomenon of aggregation, indicating that cellular mechanisms have
proven incapable of coping with the accumulation of misfolded protein. On the other
hand, evidence suggests that aggresomes provide a microenvironment that reduces the
concentration of the more toxic monomeric form of the polyQ-mutated protein.15
Moreover, Taylor et al. found aggresomes display significant chaperone, proteasome, and
autophagy activity, and that they allow for an enhanced turnover of aggregated polyQmutated protein.16 Therefore, aggresomes could enable the cell to more effectively target
its response pathways.
The ability of inclusions to enter the nucleus is a hallmark of CAG repeat
diseases. Yang et al. found that whereas cytoplasmic inclusions localized in the
perinuclear region enhanced cell survival, inclusions within the nucleus exhibited a high
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degree of toxicity.17 This group synthesized aggregates of polyQ protein in vitro and

introduced them into cultured neuronal cell nuclei by engineering a nuclear localization
signal (NLS) as part of the protein. Their findings suggest the formation of nuclear
inclusions is an important factor that influences aggregate cytotoxicity despite the
existence of cytoplasmic inclusions, which had little impact on cell survival. An
explanation for this dichotomy is that numerous transcription factors possess polyQ
regions that enable these proteins to be incorporated into nuclear inclusions via polyQmediated aggregation, with potentially detrimental effects on the regulation of gene
expression.18-20 Thus, understanding the interactions between polyQ-mutated protein
aggregates and native proteins such as those present in the nucleus is crucial to building a
more complete model of polyQ-induced pathology.
To advance this aim, various model systems have been used to investigate the
genetic dynamics of CAG repeat diseases. In particular, Drosophila melanogaster has
proven to be well suited for the study of human neurodegenerative diseases. An important
application of Drosophila melanogaster, as it relates to polyQ-related neurodegeneration,
has been its use for elucidating genes that interact with polyQ-mutated proteins to alter
the disease phenotype, so-called disease modifiers. Through the use of genetically
engineered versions of the Drosophila P-element, various groups have carried out
genome-wide mutagenesis screens that either up-regulate or down-regulate native
Drosophila genes in the presence of transgenic polyQ sequences, either the complete
human disease gene or simply the polyQ region.21-25
In the case of up-regulation, expression of target genes has often been limited to
the Drosophila eye. This has been achieved through the use of the eye-specific
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transcription factor Glass and its enhancer sequence GMR in conjunction with the yeast-

derived Gal4-UAS binary system of ectopic gene expression.26,27 Limiting this genetic
construct’s expression nearly exclusively in the eyes gives researchers flexibility to inflict
substantive damage on neuronal tissue that can be easily visualized but that will not
compromise the life of the organism, since the Drosophila eye is not an essential
structure for viability.28 However, Glass-driven transcription has been demonstrated to
take place outside of eye tissues, making it likely that “leaky” expression of those genes
under the control of Gal4-UAS will occur.29 In over-expressing ectopic polyQ proteins in
the eyes, researchers produced morphological alterations that resulted in what is
commonly referred to as a “rough” eye phenotype. Through genetic screens, numerous
modifiers that alter this rough eye phenotype, either suppressing or enhancing it, have
been discovered for several of the CAG repeat diseases, and these findings have been
used to explore possible targets for therapeutic approaches.
Until recently, it was believed that genome-wide screens for disease modifiers
could be carried out simply by combining a human polyQ protein with the up-regulated
Drosophila targeted gene in the F1 generation and looking for changes in the rough eye
defect. Nevertheless, Zhang et al. characterized a Drosophila gene, Dikar, that, when
over-expressed in combination with several types of polyQ proteins, displayed
synergistic interaction with polyQ proteins that resulted in synthetic lethality.30
Additionally, when overexpressed in the absence of polyQ, Dikar itself was able to cause
a rough eye-like phenotype. However, unlike polyQ proteins, Dikar over-expression at
high levels did not cause widespread death. These findings suggest that the current
approach used for the screening of disease modifiers in polyQ-induced neurodegeneration
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is incapable of detecting the most “reactive” modifiers, since the synthetic lethal
phenotype they produce will virtually eliminate any chances of recovering those
genotypes containing them in a usual F1 screen.
The mechanism(s) through which Dikar produces synthetic lethality remain
unclear. One possibility is related to the presumed cellular function of Dikar. Sequence
analysis has demonstrated Dikar contains an acetyl transferase domain and is the
homologue of the human CECR2 gene, a chromatin remodeling complex that is known to
activate a set of downstream genes.31,32 Because Dikar potentially plays a role in the
regulation of gene expression, its effect on polyQ cytotoxicity may involve a feedback
loop in which overexpression of Dikar drives expression of the polyQ protein above
experimentally set levels, overwhelming cellular coping mechanisms and resulting in
widespread cell death. This self-perpetuating circuit would presumably have its effect
within the region of GMR, since this sequence is the link between the expression of
Dikar and polyQ via the Gal4-UAS system (Figure 1). To determine whether this
phenomenon is responsible for the synthetic lethal phenotype, a reporter gene assay was
conducted using green fluorescent protein (GFP) as a reporter, both in the absence and
presence of Dikar overexpression.

Materials and Methods
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Culture media and Drosophila stocks: Fruit flies were raised using corn/agar media
(H2O, agar, cornmeal, baker’s yeast, table sugar, Moldex dissolved in ethanol) and
incubated at 25°C. The following alleles were obtained from the Bloomington
Drosophila Stock Center: longGMR-Gal4 (No. 8605), shortGMR-Gal4 (No. 1104), UAS2xEGFP (No. 6658). The d10135 chromosome, which carries UAS-linked Dikar, was
obtained from the Berkeley Drosophila Genome Project.

Fly dissection and fluorescence microscopy: Third instar larvae were dissected in
phosphate buffer (PBS, 130 mM NaCl, 7 mM Na2HPO4·2H2O, 3 mM NaH2PO4·2H2O,
pH 7.0) to expose and isolate eye disc structures. Tissues were mounted on slides using
cover slips and PBS, and they were immediately visualized using an Olympus
microscope. Green fluorescent images of tissues were taken with a digital camera
mounted on the microscope (CCD Spot, Diagnostic Instrument, Inc.). Images of 20
different tissue samples were taken at minimum for each of the four genotypes being
analyzed.

Image processing and statistical analysis: Digital images taken from fluorescence
microscopy were processed using the software ImageJ (The National Institutes of
Health). Images were split by color channels, and only the green channel was used for
measuring photon intensity. The “region of interest” (ROI) tool of the software was used
to draw the borders of the areas to be quantified. Areas chosen were those that displayed
intermediate intensities relative to all the signals detected for a given image. The mean
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intensity values of the designated areas were quantified by the software within a 0-255
range. These values were used to construct data sets for each of the four genotypes being
analyzed. Using the “Analysis ToolPack” add-in of Excel (2011 version), the data sets for
the control and experimental groups were statistically analyzed using the “t-Test: TwoSample Assuming Unequal Variances” setting in order to generate p values. The data set
for genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP // + ; +//+ (control) was
compared to that of genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP // UAS-Dikar ;
+//+ (experimental) and the date set for genotype +//+ ; shortGMR-Gal4 // + ; UAS2xEGFP // + ; +//+ (control) was compared to that of genotype +//+ ; shortGMR-Gal4 //
+ ; UAS-2xEGFP // UAS-Dikar ; +//+ (experimental).

Results
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Genetic manipulations to produce control genotypes: Two types of genetic crosses were
carried out to generate four genotypes of interest. The first type involved a cross of the
following genotypes: (♂) X/Y ; longGMR-Gal4 / longGMR-Gal4 ; +/+ ; +/+ X (♀) X/X
; +/+ ; UAS-2xEGFP / UAS-2xEGFP ; +/+. This cross produced an F1 generation all
containing the following autosomes: longGMR-Gal4 / + ; UAS-2xEGFP / + ; +/+.
Consequently, all members of this generation possessed fluorescence in the eye discs. An
analogous sequence was carried out using males carrying the shortGMR construct instead
of longGMR. Therefore, this type of genetic cross produced offspring containing both
GMR-Gal4, either shortGMR or longGMR, and UAS-2xEGFP (control).

Genetic manipulations to produce experimental genotypes: The second type of cross
involved more complex genetics due to the challenges posed by combining GMR-Gal4,
UAS-2xEGFP, and UAS-Dikar together in one genotype (Figure 2). Mainly,
homozygotes for GMR-Gal4 and UAS-Dikar are difficult to establish because this
genotype is unstable. Therefore, a genotype carrying both of these genetic elements in the
heterozygous condition (GMR-Gal4 on C-2 and UAS-Dikar on C-3) had to be designed
with the use of balancer chromosomes in order to suppress any recombination that would
split the UAS sequence from its downstream target gene. The type of balancer
chromosome employed was actually a set of two reciprocally translocated balancer
autosomes, represented as T(2;3)CyO-TM6, and they were established in a male line.
Due to gene dose imbalance, however, a genotype carrying the translocated
chromosomes (e.g. + ; + / T(2;3)CyO-TM6) can only produce two types of viable
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gametes: + ; + and T(2;3)CyO-TM6. Given this limitation, it was expected that only 50%
of the F1 generation that resulted from a cross of these males with females used in the
control crosses would live; that is, only those organisms carrying viable gametic
combinations. Once offspring were generated, there was an additional challenge. Due to
the genetic design, only 50% of viable offspring would display eye disc fluorescence.
The other 50% would contain the translocated balancer chromosomes in addition to UAS2xEGFP. Normally these two groups would be differentiated easily in the adult form
since the balancer chromosome contains a dominant marker: CyO. However, because the
experimental design consisted of analyzing larvae, this phenotypic distinction had not yet
developed. The means to overcome this limitation was simply to dissect larvae randomly,
knowing that each larvae chosen possessed a 50% chance of exhibiting eye disc
fluorescence. As was the case for the control, the type of genetic manipulation described
above was carried out using the longGMR-Gal4 construct in one instance and the
shortGMR-Gal4 construct in the other.

shortGMR: 20 images of tissue samples were analyzed for genotype +//+ ; shortGMRGal4 // + ; UAS-2xEGFP // + ; +//+ (Figure 4). Photon intensity data from these images
were used to calculate a mean photon intensity value of green fluorescence for this
genotype, designated “sGMR” (Table 1). This data set displayed the following
parameters: mean = 59.706, variance = 221.108. Also, 20 images of tissue samples were
analyzed for genotype +//+ ; shortGMR-Gal4 // + ; UAS-2xEGFP // UAS-Dikar ; +//+
(Figure 4). Mean photon intensity values for these images were used to calculate a mean
photon intensity value of green fluorescence for this genotype, designated “sGMR
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Dikar” (Table 1). This data set displayed the following parameters: mean = 63.541,
variance = 152.360. Both data sets were compared, and they generated a p value of 0.168.
This indicates there is no statistically significant difference between the two data sets (p <
0.05).

longGMR: 22 images of different tissue samples were analyzed for genotype +//+ ;
longGMR-Gal4 // + ; UAS-2xEGFP // + ; +//+ (Figure 4). Mean photon intensity values
for these images were used to calculate a mean photon intensity value of green
fluorescence for this genotype, designated “lGMR” (Table 1). This data set displayed the
following parameters: mean = 7.194, variance = 6.228. Also, 23 images of different
tissue samples were analyzed for genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP //
UAS-Dikar ; +//+ (Figure 4). Mean photon intensity values for these images were used to
calculate a mean photon intensity value of green fluorescence for this genotype,
designated “lGMR Dikar” (Table 1). This data set displayed the following parameters:
mean = 7.020, variance = 6.494. Both data sets (lGMR & lGMR Dikar) were compared,
and they generated a p value of 0.409. This indicates there is no statistically significant
difference between the two data sets (p < 0.05).

longGMR vs. shortGMR: Mean photon intensity values between longGMR and
shortGMR-driven expression of GFP reporter were compared (Figure 3). Since genotypes
either containing Dikar or not were not found to be statistically different, their data sets
were combined for the purposes of this comparison. The mean intensity value for
longGMR-driven expression was 12.79 while that for shortGMR-driven expression was
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123.25, indicating that shortGMR-driven expression is ~9 times greater than longGMRdriven expression.

Discussion
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The purpose of this investigation was to determine if a feedback expression loop,
involving the enhancer sequence GMR and the Drosophila protein Dikar, was the cause
of the synthetic lethality that results from the simultaneous ectopic overexpression of
human polyQ-mutated proteins and Dikar. Because the phenomenon of synthetic lethality
at present is limited to Dikar expression, a self-perpetuating circuit is a potential
explanation for this supposed isolated observation. Indeed, expression of polyQ proteins
at certain levels is sufficient to cause widespread cell death, with a feedback loop
resulting in an exact scenario.
The genetic construct used to study CAG repeat diseases in Drosophila utilizes
various genetic elements (Figure 1). A Drosophila eye-predominant transcription factor,
Glass, along with its enhancer sequence GMR, is used to virtually limit ectopic
expression to the eyes. Moreover, the yeast-derived Gal4-UAS system is used to drive
expression of target genes. These two elements are linked via the GMR-Gal4 construct,
which ultimately combines Glass-induced transcription to the expression of genes
downstream of UAS sequences. Within this genetic construct, a potential weakness
involves the ability of target genes to modulate the dynamics of either Glass or the GMR
sequence, thereby altering the experimentally pre-determined expression levels of the
target genes. In considering Dikar and its cellular role in the regulation of gene
expression via chromatin remodelling, synthetic lethality can be the result of Dikarinduced changes on the GMR sequence, which would lead to increased expression of
Gal4 and thus of the polyQ-containing protein.
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A reporter gene assay using green fluorescent protein (GFP) was carried out to
determine Dikar’s effect on GMR-driven expression of target genes. The experimental
design consisted of the following elements. First, two common GMR derivatives were
used: longGMR (lGMR) and shortGMR (sGMR). The primary differences between these
two are: 1) longGMR carries more Glass-binding sites than shortGMR and 2) shortGMR
achieves greater levels of expression in the eyes than does longGMR. Two versions of
GMR were used to further validate the experimental findings inasmuch as both GMR
sequences yield the same results. Second, 2 types of genotypes were generated for each
GMR sequence (4 genotypes of interest in total). One type contained the GMR-Gal4 and
UAS-2xEGFP constructs only and served as a control to establish baseline expression of
the GMR sequence. The other genotype contained the GMR-Gal4 and UAS-2xEGFP
constructs as well as UAS-Dikar (Figure 2), and it served to determine Dikar’s effect, if
any, on the expression of GMR-controlled genetic elements.
GFP reporter expression was measured using fluorescence microscopy. In order
to optimize visualization of the green fluorescence signal, eye tissue samples were
obtained from third instar larvae. In particular, eye discs, primordial structures of the
adult eye, were dissected out and prepared for microscopy. This made for a more efficient
means of obtaining appropriate tissues without the need to process tough, adult cuticle.
Simultaneous to visualization, tissue samples were imaged using a CCD camera to reduce
“background” signals. No qualitative difference was observed between those genotypes
possessing the same GMR sequence either in the absence or presence of Dikar (Figure 4).
Subsequently, images were processed, and this data was used to generate quantitative
mean photon intensity values for each of the four genotypes of interest (Table 1).
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Statistical analysis of these values demonstrated no significant difference between
genotypes possessing the same GMR sequence either in the absence or presence of Dikar.
Moreover, the difference in reporter expression observed between the longGMR and
shortGMR constructs (Figure 3) reflected the dynamics of these two sequences found in
the literature. This outcome validated both the genetic design as well as the experimental
findings.

Given this data, it was concluded that Dikar did not affect GMR-driven

expression of the GFP reporter.
Therefore, the experimental results did not support the concept of a Dikar
expression feedback loop as the causation of polyQ-related synthetic lethality in
Drosophila. These findings have two major implications. First, a discrediting of the
expression feedback loop hypothesis posits a more complex relation between polyQmutated proteins and Dikar. Based on the experimental results, it is likely that synthetic
lethality is the product of either direct or indirect interactions between these two gene
products. As such, further research on the mechanism(s) by which Dikar causes synthetic
lethality is needed. Second, the probability that Dikar is the only gene capable of eliciting
a “legitimate” synthetic lethal phenotype seems unlikely. Given this assumption, the
current approach to finding polyQ disease modifiers in Drosophila via genome-wide
screens appears to have a major flaw. Simply stated, these screens are unable to recover
the most powerful modifiers: those that modify polyQ cytotoxicity to the point of death.
Thus, a re-evaluation of this protocol that reflects this reality is necessary for the
discovery of genes that may ultimately serve as therapeutic targets for these diseases.

Literature Cited

22

1. Ross CA, Poirier MA. Protein Aggregation and Neurodegenerative Disease. Nature
Medicine 10.7: S10-17, 2004.
2. Housman D. Gain of glutamines, gain of function? Nature Genet 10: 3-4, 1995
3. Petruska J, Hartenstein MJ, Goodman MF. Analysis of Strand Slippage in DNA
Polymerase Expansions of CAG/CTG Triplet Repeats Associated with
Neurodegenerative Disease. Journal of Biological Chemistry273: 5204-210, 1998.
4. Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood of
being affected with Huntington disease by a particular age, for a specific CAG size. Am J
Hum Genet; 60:1202–1210, 1997.
5. Zuccato C, Valenza M, Cattaneo E. Molecular Mechanisms and Potential Therapeutical
Targets in Huntington’s Disease. Physiological Reviews90.3: 905-81, 2010.
6. Ross CA. When more is less: pathogenesis of glutamine repeat neurodegenerative
diseases. Neuron 15: 493-6, 1995
7. Bates GPHP, Jones AL. Huntington’s Disease. Oxford, UK: Oxford Univ. Press, 2002.
8. Cisbani, G, Cicchetti F. An in Vitro Perspective on the Molecular Mechanisms
Underlying Mutant Huntingtin Protein Toxicity. Cell Death and Disease 382: n. pag.,
2012
9. Rosenblatt A. Neuropsychiatry of Huntington’s disease. Dialogues Clin Neurosci 9: 191–
197, 2007
10. Harjes P, Wanker EE. The hunt for huntingtin function: interaction partners tell many
different stories. Trends Biochem Sci 28: 425–433, 2003.
11. Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, et al. Depletion of wildtype huntingtin in mouse models of neurologic diseases. J Neurochem.; 87:101–106.
2003.
12. Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes H, Murphy Z, Graham RK, et al.
Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem.; 96:1121–1129,
2006.
13. Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes H, Murphy Z, Graham RK, et al.
Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem.; 96:1121–1129,
2006.
14. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and
Aronin, N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic
neurites in brain. Science, 277, 1990–1993, 1997.
15. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation
reduces levels of mutant huntingtin and the risk of neuronal death. Nature.; 431:805–810,
2001.
16. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic-Plese S, et al.
Aggresomes protect cells by enhancing the degradation of toxic polyglutaminecontaining protein. Hum Mol Genet.;12:749–757, 2003.
17. Yang W, Dunlap JR, Andrews RB, Wetzel R. Aggregated polyglutamine peptides
delivered to nuclei are toxic to mammalian cells. Hum Mol Genet 11: 2905–2917, 2002.
18. Nucifora, F.C., Jr., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K.,Yamada, M.,
Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L. et al. (2001) Interference by
huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
Science, 291, 2423–2428.
19. McCampbell, A. and Fischbeck, K.H. (2001) Polyglutamine and CBP: fatal attraction?
Nat. Med., 7, 528–530.

23

20. Okazawa, H., Rich, T., Chang, A., Lin, X., Waragai, M., Kajikawa, M., Enokido, Y.,
Komuro, A., Kato, S., Shibata, M. et al. (2002) Interaction between mutant ataxin-1 and
PQBP-1 affects transcription and cell death. Neuron, 34, 701–713
21. P Fernandez-Funez, ML Nino-Rosales, B de Gouyon, WC She, JM Luchak, P Martinez,
E Turiegano, J Benito, M Capovilla, PJ Skinner, et al: Identification of genes that modify
ataxin-1-induced neurodegeneration. Nature 2000, 408:101-6.
22. P Kazemi-Esfarjani, S Benzer: Genetic suppression of polyglutamine toxicity in
Drosophila. Science 2000, 287:1837-40.
23. J Bilen, NM Bonini: Genome-wide screen for modifiers of ataxin-3 neurodegeneration in
Drosophila. PLoS Genet 2007, 3:1950-64.
24. S Zhang, R Binari, R Zhou, N Perrimon: A genomewide RNA interference screen for
modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2010,
184:1165-79.
25. H Vossfeldt, M Butzlaff, K Prussing, RA Ni Charthaigh, P Karsten, A Lankes, S Hamm,
M Simons, B Adryan, JB Schulz, et al: Large-scale screen for modifiers of ataxin-3derived polyglutamine-induced toxicity in Drosophila. PLoS One 2012, 7:e47452.
26. Moses, K., G. M. Rubin. Glass Encodes a Site-specific DNA-binding Protein That Is
Regulated in Response to Positional Signals in the Developing Drosophila Eye. Genes &
Development 5.4: 583-93, 1994
27. Southall, T. D., D. A. Elliott, and A. H. Brand. The GAL4 System: A Versatile Toolkit
for Gene Expression in Drosophila. Cold Spring Harbor Protocols 2008.8: Pdb.top49,
2008
28. Halder, G., P. Callaerts, S. Flister, U. Walldorf, U. Kloter, and W. J. Gehring. Eyeless
Initiates the Expression of Both Sine Oculis and Eyes Absent during Drosophila
Compound Eye Development. Development 125: 2181-191, 1998
29. MC Ellis, EM O'Neill, GM Rubin: Expression of Drosophila glass protein and evidence
for negative regulation of its activity in non-neuronal cells by another DNA-binding
protein. Development 1993, 119:855-65.
30. P. Zhang, Q. Wang, H. Hughes, G. Intrieri, D. Camacho. Synthetic Lethality Induced by
Coexpressing the Drosophila Dikar Gene and an Expended Polyglutamine Tract with the
GMR-Gal4/UAS System. (2013, Manuscript in preparation)
31. Keuling, A., F. Yang, S. Hanna, H. Wang, T. Tully, A. Burnham, J. Locke, and H.
McDermid. Mutation Analysis of Drosophila Dikar/CG32394, Homologue of the
Chromatin-remodelling Gene CECR2. Genome 50: 767-77, 2007
32. Fairbridge, Nicholas A., Christine E. Dawe, Farshad H. Niri, Megan K. Kooistra, Kirst
King-Jones, and Heather E. McDermid. Cecr2 Mutations Causing Exencephaly Trigger
Misregulation of Mesenchymal/ectodermal Transcription Factors. Birth Defects Research
Part A: Clinical and Molecular Teratology 88.8: 619-25, 2010

Parameters
Mean
Variance
Observations
Pearson Correlation
Hypothesized Mean Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

sGMR
59.706
221.108
20.000
0.199
0.000
19.000
-0.989
0.168
1.729
0.335
2.093

sGMR Dikar
63.541
152.360
20.000
-

lGMR
7.195
6.228
22.000
6.364
0.000
43.000
0.232
0.409
1.681
0.818
2.017
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lGMR Dikar
7.020
6.494
23.000
-

Table 1. Average photon intensity values & statistical analysis data. Mean value
comparison between data sets of genotypes sGMR (59.706) and sGMR Dikar (63.541)
determined no statistically significant difference between the two (p value = 0.168).
Similarly, the comparison between data sets of genotypes lGMR (7.195) and lGMR Dikar
(7.020) determined no statistically significance difference between the two (p value =
0.409). Therefore, expression of Dikar does not impact expression of GMR-driven
expression (either longGMR or shortGMR) of GFP reporter.
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Figure 1. Hypothetical Dikar expression feedback loop. A) Eye-predominant
transcription factor Glass binds to its enhancer sequence, GMR, and drives transcription
of Gal4 gene. B) Gal4 binds its enhancer sequence, UAS, and activates transcription of
downstream genes; in this genetic construct these are the Drosophila gene Dikar and a
human polyQ-containing transgene. C) Dikar is able to affect GMR-driven transcription,
perhaps through chromatin remodelling, and causes expression of the Gal4 gene above
experimentally-set levels. D) An increased dose of Gal4 drives increased expression of
the polyQ-disease protein, which acts as a cytotoxin and whose level of expression
overwhelms cellular coping mechanisms. This self-perpetuating feedback circuit is one
supposed mechanism by which Dikar expression, in combination with polyQ expression,
leads to a synthetic lethal phenotype in Drosophila.
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Figure 2. Genetic design to generate experimental genotypes. Top) Males carrying the
translocated balancer chromosome T(2;3) CyO-TM6 (represented as “T(2;3) a” & “T(2;3)
b”) only produced two sets of viable gametes. Bottom) Cross to generate experimental
genotypes (lGMR Dikar and sGMR Dikar) produced two distinct autosomal genotypes
in the F1 generation. Out of these, only the one carrying the GMR-Gal4 construct
displayed green fluorescence in eye discs of larvae.
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Figure 3. longGMR vs. shortGMR-driven expression of GFP reporter. Experimental
findings presented in Table 1 demonstrated no difference between GMR-driven
expression of GFP reporter either in the presence or absence of Dikar expression (p >
0.05). Therefore, both genetic constructs for each GMR type, long and short, were used
for the purpose of comparing levels of expression between longGMR and shortGMR.
Graph shows shortGMR caused ~9-fold greater level of GFP reporter expression than
longGMR.
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Figure 4. Representative fluorescence microscopy images of larval eye disc structures.
A-D) Eye discs dissected from “sGMR” genotype. E-H) Eye discs dissected from
“sGMR Dikar” genotype. There is no obvious difference in mean photon intensity
between images A-D and images E-H, indicating no qualitative impact of Dikar
expression on sGMR-driven expression of GFP reporter. I-L) Eye discs dissected from
“lGMR” genotype. M-P) Corresponding digitally enhanced versions of I-L for the
purpose of visualizing eye disc structures present in image. Q-T) Eye discs dissected
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from “lGMR Dikar” genotype. U-X) Corresponding digitally enhanced versions of
images Q-T for the purpose of visualizing eye disc structures present in image.
Analogous to sGMR, there is no obvious difference in mean photon intensity between

images I-L and images Q-T, indicating no qualitative impact of Dikar expression on
lGMR-driven expression of GFP reporter.

